Litigation Details for Thomsen v. Mylan Specialty L.P. (E.D. Mich. 2016)
✉ Email this page to a colleague
Thomsen v. Mylan Specialty L.P. (E.D. Mich. 2016)
| Docket | ⤷ Subscribe | Date Filed | 2016-08-23 |
| Court | District Court, E.D. Michigan | Date Terminated | 2017-01-19 |
| Cause | 28:1332 Diversity-(Citizenship) | Assigned To | Gershwin Allen Drain |
| Jury Demand | Plaintiff | Referred To | Stephanie Dawkins Davism |
| Parties | MYLAN PHARMACEUTICALS INC. | ||
| Patents | 7,449,012; 7,794,432; 8,048,035; 8,870,827 | ||
| Attorneys | E. Powell Miller | ||
| Firms | Bush Seyferth PLLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Thomsen v. Mylan Specialty L.P.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for Thomsen v. Mylan Specialty L.P. (E.D. Mich. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-11-22 | 19 | ; 7,794,432; 8,048,035; and 8,870,827, of which the court may take judicial notice. See Anderson v. Kimberly-Clark…regulate the price of patented EpiPen devices, their claims are preempted by federal patent law. There is another…Rule 12(b)(6). 2 The patents on the EpiPen Auto-Injector device include U.S. Patent numbers 7,449,012; …51 is “the promulgator of patent policy,” and that federal patent law reflects the results of Congress… the pricing of a patented pharmaceutical product are preempted by federal patent law. The decision | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
